U Tebbe

Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) Study.

Rolf Schröder, K. L. Neuhaus, T. Linderer et al. · PubMed · 1987 · 32 citations

Medicine, Cardiology, Pharmacology +13

Recombinant hirudin and front-loaded alteplase in acute myocardial infarction: Final results of a pilot study HIT-I (hirudin for the improvement of thrombolysis)

Uwe Zeymer, R. von Essen, U Tebbe et al. · European Heart Journal · 1995 · 28 citations

Medicine, Cardiology, Pharmacology +14

Quantitative bedside testing of troponin T: is it equal to laboratory testing? The Cardiac Reader Troponin T (CARE T) study.

Britta Goldmann, Lukas Langenbrink, Guido Matschuck et al. · PubMed · 2004 · 20 citations

Medicine, Cardiology, Internal Medicine +16

[Cardioversion in atrial fibrillation. Results and complications in 1,152 prospective patients. Study Group of the Working Society of Leading Cardiologic Hospital Physicians].

U Tebbe, J. Carlsson, K. Seidl et al. · PubMed · 1995 · 14 citations

Medicine, Cardiology, Internal Medicine +9

Controversial indications: Rationale for thrombolysis: later than 4-6 h from symptom onset, and in patients with smaller myocardial infarctions

Rolf Schröder, T. Linderer, Kristin Brüggemann et al. · European Heart Journal · 1990 · 13 citations

Medicine, Cardiology, Clinical Cardiology +14